NTR-441

N/A

Report date: 2024/11/11 15:40:06
NME

Base Information

Drug NameNTR-441
Drug Alias NameNTR-441
ClassificationSmall molecules
Mechanisms of ActionNeutrophil Extracellular Traps scavengers
TargetsNeutrophil Extracellular Traps
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkraineAustria
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeutrolis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeutrolis Inc
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A